Home / Drug shortages / Lidocaine Hydrochloride Injection

Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-4282-02
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)
Initial Posting
02/22/2012
Revised Date

FDA data resources